Company Profile for Pharmalucence, Inc.

--(BUSINESS WIRE)-- Pharmalucence is a leader in the supply of radiopharmaceuticals, supporting the needs of nuclear medicine practitioners and their radiopharmacy affiliates. The company is also an emerging presence in drug contract services including process development and parenteral drug manufacture at both the clinical trial and commercial scale.

Company:

    Pharmalucence, Inc.
 

Headquarters Address:

10 DeAngelo Drive
Bedford, MA 01730
 

Main Telephone:

7812757120
 

Website:

www.pharmalucence.com

 

Type of Organization:

Private
 

Industry:

Pharmaceutical
 

Key Executives:

CEO: Glenn Alto

COO: Edward Connolly

CFO: Bill Waters

 

Public Relations

Contact:

Glenn Alto

Phone:

7816871204

Email:

[email protected]

 

Investor Relations

Contact:

Bill Waters

Phone:

7816871200

Email:

[email protected]



KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Cardiology  Medical Devices  Pharmaceutical  Radiology  FDA

MEDIA:

Logo
 Logo

Suggested Articles

Paragon Biosciences has hired Kerensa Jimenez as the new CEO of its capital markets group Paragon Health Capital.

Regeneron has taken a step closer to getting a green light for its experimental high cholesterol drug as the FDA allows a swift review of evicanumab.

An analysis of Gilead’s remdesivir clinical trials found the studies “failed to provide equal representation of Black, Latinx and Native Americas."